ERBB2 and gastric cancer: The Japanese Gastric Cancer Treatment Guidelines recommend systemic chemotherapy with platinum agents and fluoropyrimidine, plus trastuzumab or nivolumab depending on HER2 status, for unresectable or recurrent GC.